Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023
   Working Capital/Sales(x) 1.930.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 1.93 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.93
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2025 1.93
144.30
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹86.9 Cr -11.8% -16% -46.7% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,125.4 Cr -1.8% -13.1% 14.8% Stock Analytics
KIRI INDUSTRIES ₹3,234.9 Cr -4.2% -10.4% 40.2% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,690.4 Cr 0.4% -6.8% -28.2% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,273.9 Cr -7.5% -10% 54.9% Stock Analytics
BODAL CHEMICALS ₹768.3 Cr -1.5% -2.7% -18.8% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-11.8%

-16%

-46.7%

SENSEX

-1.4%

3.1%

3.8%


You may also like the below Video Courses